Antony A Riley Net Worth

The estimated Net Worth of Antony A Riley is at least $1.8 Million dollars as of 19 November 2019. Antony Riley owns over 6,250 units of Krystal Biotech Inc stock worth over $1,799,050 and over the last 7 years Antony sold KRYS stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Antony Riley KRYS stock SEC Form 4 insiders trading

Antony has made over 2 trades of the Krystal Biotech Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Antony exercised 6,250 units of KRYS stock worth $61,563 on 19 November 2019.

The largest trade Antony's ever made was exercising 6,250 units of Krystal Biotech Inc stock on 19 November 2019 worth over $61,563. On average, Antony trades about 2,263 units every 155 days since 2018. As of 19 November 2019 Antony still owns at least 9,050 units of Krystal Biotech Inc stock.

You can see the complete history of Antony Riley stock trades at the bottom of the page.

What's Antony Riley's mailing address?

Antony's mailing address filed with the SEC is 2100 Wharton St #701, Pittsburgh, PA 15203, USA.

Insiders trading at Krystal Biotech Inc

Over the last 7 years, insiders at Krystal Biotech Inc have traded over $166,816,526 worth of Krystal Biotech Inc stock and bought 536,800 units worth $5,949,380 . The most active insiders traders include Daniel Janney, Dino A Rossi, and Krish S Krishnan. On average, Krystal Biotech Inc executives and independent directors trade stock every 40 days with the average trade being worth of $8,043,043. The most recent stock trade was executed by Suma Krishnan on 11 June 2024, trading 50,000 units of KRYS stock currently worth $8,788,000.

What does Krystal Biotech Inc do?

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)

Complete history of Antony Riley stock trades at Krystal Biotech Inc

Krystal Biotech Inc executives and stock owners

Krystal Biotech Inc executives and other stock owners filed with the SEC include:

• Krish S. Krishnan M.B.A., M.S.,
  Founder, Chairman, Pres & CEO
• Krish S. Krishnan,
  Chairman, Pres & CEO
• Dr. Andreas C. Orth,
  Exec. VP & Chief Commercial Officer
• Suma M. Krishnan,
  Founder, COO & Director
• Krish Krishnan,
  Chairman of the Board, President, Chief Executive Officer
• Suma Krishnan,
  Founder, Chief Operating Officer, Director
• Pooja Agarwal,
  Senior Vice President, Product Development
• Kathryn A. Romano,
  Chief Accounting Officer
• R. Douglas Norby,
  Lead Independent Director
• Dino Rossi,
  Independent Director
• Daniel Janney,
  Independent Director
• Julian Gangolli.,
  Independent Director
• Ashley Robinson,
  IR Contact Officer
• Kirti Ganorkar,
  Independent Director
• J. Christopher Naftzger,
  Chief Legal Officer, Corporate Secretary
• Jennifer Chien,
  Chief Commercial Officer
• Kathryn Romano,
  Chief Accounting Officer
• David Glynn,
  Gen. Counsel, Commercial & Compliance
• Meg Dodge,
  VP of Investor Relations & Corp. Communications
• Dr. Jing L. Marantz M.B.A., M.D., Ph.D.,
  Chief Bus. Officer
• Pooja Agarwal,
  Sr. VP of Product Devel.
• Whitney Glad Ijem,
  Sr. VP of Strategy & Bus. Devel.
• Josh Suskin,
  Director of HR & Operations
• Katherine Tuminello,
  HR & Office Mang.
• John Karakkal,
  VP of North American Sales and Marketing
• Gloria Lin,
  Accounting Mang.
• Catherine Mazzacco,
  Director
• Krish S Krishnan,
  President and CEO
• Antony A Riley,
  Chief Financial Officer
• Jennifer Kayden Lee,
  Chief Commercial Officer
• Christopher Mason,
  Director
• Jing L. Marantz,
  Chief Business Officer
• Everett Rand Sutherland,
  Director